CP Reports Store

Welcome to the home of CP Reports, we are the only publisher of life science deal term reports in the industry.

CP Reports Store offers over 100 report titles that focus upon different deal types and technology or therapy areas including licensing, collaborative R&D, co-promotion, biomarkers, diagnostics, oncology, immunology all of which provide a detailed insight into the latest life science deal making trends.

Browse our reports by type to find your ideal match.

 

Our reports are updated regularly and include full coverage of the latest deals in the chosen report type.

Unsure which report to select? Contact our report analysts who will assist your decision.

Items 1-10 of 50

Page
per page
Set Ascending Direction
  1. Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2020
    Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2020
    April 2020
    $3,495.00

    Essential Benchmark Data for Dealmakers - The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2020 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments.

    Learn More
  2. Global Autoimmune Partnering 2014-2020: Deal trends, players and financials
    Global Autoimmune Partnering 2014-2020: Deal trends, players and financials
    April 2020
    $3,495.00

    The Global Autoimmune Partnering 2014-2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the autoimmune disease partnering deals and agreements entered into by the worlds leading healthcare companies

    Learn More
  3. Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020
    Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.

    Learn More
  4. Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020
    Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  5. Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  6. Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies

    Learn More
  7. Global Dermatology Partnering 2014-2020: Deal trends, players and financials
    Global Dermatology Partnering 2014-2020: Deal trends, players and financials
    April 2020
    $3,495.00

    The Global Dermatology Partnering 2014-2020 report provides comprehensive understanding and unprecedented access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies

    Learn More
  8. Global Central Nervous System Partnering 2014 to 2020: Deal trends, players and financials
    Global Central Nervous System Partnering 2014 to 2020: Deal trends, players and financials
    April 2020
    $3,495.00

    The Global Central Nervous System Partnering 2014 to 2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the central nervous system (cns) partnering deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  9. Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2014-2020
    Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.

    Learn More
  10. Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020
    Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

    Learn More

Items 1-10 of 50

Page
per page
Set Ascending Direction